Plasma Aβ42/Aβ40 ratio

There are 14 papers on plasma Aβ42/Aβ40 ratio in aging research: 10 observational studies in people, 1 in animals, 2 reviews.

Biomarker

14 papers study it8 more mention it14 findings

See all 22 papers on plasma Aβ42/Aβ40 ratio

“higher AgeAccelHorvath and AgeAccelPheno were associated with lower amyloid beta (Aβ) 42 to Aβ40 (Aβ42:Aβ40) ratio”
Epigenetic clocks and longitudinal plasma biomarkers of Alzheimer's diseaseAlzheimer's & dementia : the journal of the Alzheimer's Association2025doi:10.1002/alz.70983
  • Humans10
  • Animals1
  • In silico1

Effects

2

Late-onset epilepsy

no changein humans1

1 study
  1. Plasma Aβ42/Aβ40 ratio was not clearly linked with late-onset epilepsy in humans (Isolated measurement).

    HumansIsolated measurementplasman = 1,424

More on Late-onset epilepsy

Cortical metabolism

no changein humans1

1 study
  1. Plasma Aβ42/Aβ40 ratio was not clearly linked with cortical metabolism in humans (subjective memory complaints).

    Humanssubjective memory complaintsbrainn = 261

Associations

12

CSF Aβ42/Aβ40 ratio

upin mice1

1 study
  1. Plasma Aβ42/Aβ40 ratio is associated with CSF Aβ42/Aβ40 ratio in preclinical 5XFAD mice.

    Animalsin preclinical 5XFAD mice

More on CSF Aβ42/Aβ40 ratio

PSEN1 E280A mutation carrier status

mixedin humans1

1 study
  1. Plasma Aβ42/Aβ40 ratio predicts PSEN1 E280A mutation carrier status in humans (classification of carriers versus non-carriers by ROC curve) (AUC 0.99).

    Humansclassification of carriers versus non-carriers by ROC curven = 164

PSEN1

mixedin humans1

1 study
  1. PSEN1 is associated with plasma Aβ42/Aβ40 ratio in humans (carriers versus non-carriers; divergence age) (divergence before age 18 (Aβ42/Aβ40); 26.0 years (p-tau217); 26.1 years (GFAP); 27.9 years (BD-tau); 38.7 years (NfL)).

    Humanscarriers versus non-carriers; divergence agen = 164

More on PSEN1

Progression from PET A- to A+

upin humans1

1 study
  1. Plasma Aβ42/Aβ40 ratio predicts progression from PET A- to A+ in PET A- non-demented participants.

    Humansin PET A- non-demented participants

PET Aβ burden

upin humans1

1 study
  1. Plasma Aβ42/Aβ40 ratio predicts PET Aβ burden in PET A- non-demented participants.

    Humansin PET A- non-demented participants

More on PET Aβ burden

Amyloid PET positivity

upin humans1

1 study
  1. Plasma Aβ42/Aβ40 ratio predicts amyloid PET positivity in humans (AUC 0.856).

    Humansn = 474

More on Amyloid PET positivity

Brain amyloid burden

upin humans1

1 study
  1. Plasma Aβ42/Aβ40 ratio is associated with brain amyloid burden in humans.

    Reviewplasma

More on Brain amyloid burden

AgeAccelPheno

downin humans1

1 study
  1. AgeAccelPheno is associated with plasma Aβ42/Aβ40 ratio in humans (at baseline; same association for AgeAccelHorvath).

    Humansat baseline; same association for AgeAccelHorvathfemales

More on AgeAccelPheno

AgeAccelHorvath

downin humans1

1 study
  1. AgeAccelHorvath is associated with plasma Aβ42/Aβ40 ratio in humans (at baseline; same association for AgeAccelPheno).

    Humansat baseline; same association for AgeAccelPhenofemales

More on AgeAccelHorvath

Cognitive function

mixedin humans1

1 study
  1. Plasma Aβ42/Aβ40 ratio is associated with cognitive function in humans (patients receiving hemodialysis; adjusted for age, sex and education levels).

    Humanspatients receiving hemodialysis; adjusted for age, sex and education levels55% malesn = 311

All 12

Latest

Dec 2025: 5Jan 2026: 0Feb 2026: 1Mar 2026: 1Apr 2026: 1May 2026: 2Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 011 papers in 12 months

See all 22 papers on plasma Aβ42/Aβ40 ratio